Development of a new positron emission tomography tracer for targeting tumor angiogenesis: Synthesis, small animal imaging, and radiation dosimetry

Molecules

Volumn 18, Issue 5, 2013, Pages 5594-5610

  Patterson, Cam ^a,b   Frederick, C Brandon ^a,c   Yuan, Hong ^a   Dyer, Laura A ^a   Lockyer, Pamela ^a   Lalush, David S ^a,c   Veleva, Anka N ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Development of new 64Cu radiolabeled peptide; Positron emission tomography (PET) imaging; Radiopharmaceuticals; Responses to therapy; Targeted radioconjugates; Tumor aggressiveness; Tumor angiogenesis

Indexed keywords

COPPER; ISOTOPE; PEPTIDE; RADIOPHARMACEUTICAL AGENT;

ANIMAL; ARTICLE; CHEMISTRY; FEMALE; LEWIS CARCINOMA; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SYNTHESIS;

ANIMALS; CARCINOMA, LEWIS LUNG; COPPER; FEMALE; ISOTOPES; MICE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84878290379     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18055594     Document Type: Article

References (43)

1. Rafii, S.; Lyden, D.; Benezra, R.; Hattori, K.; Heissig, B. Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat. Rev. Cancer 2002, 2, 826-835. (Pubitemid 37328901)
2. Lyden, D.; Hattori, K.; Dias, S.; Costa, C.; Blaikie, P.; Butros, L.; Chadburn, A.; Heissig, B.; Marks, W.; Witte, L.; et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001, 7, 1194-1201. (Pubitemid 33063774)
3. Duda, D.G.; Cohen, K.S.; Kozin, S.V.; Perentes, J.Y.; Fukumura, D.; Scadden, D.T.; Jain, R.K. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 2006, 107, 2774-2776.
4. Aitsebaomo, J.; Srivastava, S.; Zhang, H.; Jha, S.; Wang, Z.J.; Winnik, S.; Veleva, A.N.; Pi, X.C.; Lockyer, P.; Faber, J.E.; et al. Recombinant human interleukin-11 treatment enhances collateral vessel growth after femoral artery ligation. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 306-312.
5. Lyden, D.; Hattori, K.; Dias, S.; Hajjar, K.; Manova, K.; Moore, M.A.S.; Benezra, R.; Rafii, S. Transplantation of bone marrow derived VEGF-responsive hematopoietic and vasculogenic precursor cells are essential to restore the angiogenic defect in Id1+/-Id3-/- knock out mice. Blood 2000. 96, 529A.
6. Zhang, H.; Vakil, V.; Braunstein, M.; Smith, E.L.P.; Maroney, J.; Chen, L.; Dai, K.Z.; Berenson, J.R.; Hussain, M.M.; Klueppelberg, U.; et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 2005, 105, 3286-3294.
7. Furstenberger, G.; von Moos, R.; Lucas, R.; Thurlimann, B.; Senn, H.J.; Hamacher, J.; Boneberg, E.M. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br. J. Cancer 2006, 94, 524-531. (Pubitemid 43289756)
8. Dome, B.; Timar, J.; Dobos, J.; Meszaros, L.; Raso, E.; Paku, S.; Kenessey, I.; Ostoros, G.; Magyar, M.; Ladanyi, A.; et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res. 2006, 66, 7341-7347. (Pubitemid 44197717)
9. Rafat, N.; Beck, G.C.; Schulte, J.; Tuettenberg, J.; Vajkoczy, P. Circulating endothelial progenitor cells in malignant gliomas Clinical article. J. Neurosurg. 2010, 112, 43-49.
10. Roodhart, J.M.; Langenberg, M.H.; Vermaat, J.S.; Lolkema, M.P.; Baars, A.; Giles, R.H.; Witteveen, E.O.; Voest, E.E. Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients. Neoplasia 2010, 12, 87-94.
11. Duda, D.G.; Cohen, K.S.; di Tomaso, E.; Au, A.P.; Klein, R.J.; Scadden, D.T.; Willett, C.G.; Jain, R.K. Differential CD 146 expression on circulating versus tissue endothelial cells in rectal cancer patients: Implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J. Clin. Oncol. 2006, 24, 1449-1453. (Pubitemid 46622012)
12. Pasqualini, R.; Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature 1996. 380, 364-366. (Pubitemid 26097120)
13. Hamzah, J.; Kotamraju, V.R.; Seo, J.W.; Agemy, L.; Fogal, V.; Mahakian, L.M.; Peters, D.; Roth, L.; Gagnon, M.K.J.; Ferrara, K.W.; et al. Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA 2011. 108, 7154-7159.
14. Chen, K.; Ma, W.H.; Li, G.Q.; Wang, J.; Yang, W.D.; Yap, L.P.; Hughes, L.D.; Park, R.; Conti, P.S. Synthesis and evaluation of Cu-64-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression. Mol. Pharm. 2013, 10, 417-427.
15. Chen, K.; Sun, X.L.; Niu, G.; Ma, Y.; Yap, L.P.; Hui, X.L.; Wu, K.C.; Fan, D.M.; Conti, P.S.; Chen, X.Y. Evaluation of Cu-64 labeled GX1: A phage display peptide probe for PET imaging of tumor vasculature. Mol. Imaging Biol. 2012, 14, 96-105.
16. Gronwall, C.; Stahl, S. Engineered affinity proteins-Generation and applications. J. Biotechnol. 2009. 140, 254-269.
17. Nilsson, F.Y.; Tolmachev, V. Affibody (R) molecules: New protein domains for molecular imaging and targeted tumor therapy. Curr. Opin. Drug Discov. Dev. 2007, 10, 167-175. (Pubitemid 46438646)
18. Tolcher, A.W.; Sweeney, C.J.; Papadopoulos, K.; Patnaik, A.; Chiorean, E.G.; Mita, A.C.; Sankhala, K.; Furfine, E.; Gokemeijer, J.; Iacono, L.; et al. Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin. Clin. Cancer Res. 2011, 17, 363-371.
19. Skerra, A. Alternative binding proteins: Anticalins-harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities. FEBS J. 2008, 275, 2677-2683. (Pubitemid 351678679)
20. Klevenz, B.; Butz, K.; Hoppe-Seyler, F. Peptide aptamers: Exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding. Cell. Mol. Life Sci. 2002, 59, 1993-1998. (Pubitemid 36015871)
21. Silverman, J.; Lu, Q.; Bakker, A.; To, W.; Duguay, A.; Alba, B.M.; Smith, R.; Rivas, A.; Li, P.; Le, H.; et al. Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains. Nat. Biotechnol. 2005, 23, 1556-1561. (Pubitemid 41752934)
22. Steiner, D.; Forrer, P.; Pluckthun, A. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display. J. Mol. Biol. 2008, 382, 1211-1227.
23. Haubner, R.; Beer, A.J.; Wang, H.; Chen, X.Y. Positron emission tomography tracers for imaging angiogenesis. Eur. J. Nucl. Med. Mol. Imaging 2010, 37, S86-S103.
24. Nayak, T.K.; Brechbiel, M.W. Radioimmunoimaging with longer-lived positron-emitting radionuclides: Potentials and challenges. Bioconjug. Chem. 2009, 20, 825-841.
25. Anderson, C.J.; Jones, L.A.; Bass, L.A.; Sherman, E.L.C.; McCarthy, D.W.; Cutler, P.D.; Lanahan, M.V.; Cristel, M.E.; Lewis, J.S.; Schwarz, S.W. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J. Nucl. Med. 1998, 39, 1944-1951. (Pubitemid 28518897)
26. Lewis, J.S.; Lewis, M.R.; Cutler, P.D.; Srinivasan, A.; Schmidt, M.A.; Schwarz, S.W.; Morris, M.M.; Miller, J.P.; Anderson, C. J. Radiotherapy and dosimetry of Cu-64-TETA-Tyr(3)-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. Clin. Cancer Res. 1999, 5, 3608-3616.
27. Rogers, B.E.; Bigott, H.M.; McCarthy, D.W.; Della Manna, D.; Kim, J.; Sharp, T.L.; Welch, M.J., MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a Cu-64-labeled bombesin analogue. Bioconjug. Chem. 2003, 14, 756-763. (Pubitemid 36875435)
28. Prasanphanich, A.F.; Nanda, P.K.; Rold, T.L.; Ma, L.X.; Lewis, M.R.; Garrison, J.C.; Hoffman, T.J.; Sieckman, G.L.; Figueroa, S.D.; Smith, C.J., Cu-64-NOTA-8-Aoc-BBN(7-14)NH2 targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues. Proc. Natl. Acad. Sci. USA 2007, 104, 12462-12467. (Pubitemid 47206160)
29. Gaertner, F.C.; Kessler, H.; Wester, H.J.; Schwaiger, M.; Beer, A. J. Radiolabelled RGD peptides for imaging and therapy. Eur. J. Nucl. Med. Mol. Imaging 2012, 39, 126-138.
30. Dumont, R.A.; Deininger, F.; Haubner, R.; Maecke, H.R.; Weber, W.A.; Fani, M. Novel Cu-64- and Ga-68-Labeled RGD conjugates show improved PET imaging of alpha(v)beta(3) integrin expression and facile radiosynthesis. J. Nucl. Med. 2011, 52, 1276-1284.
31. Nielsen, C.H.; Kimura, R.H.; Withofs, N.; Tran, P.T.; Miao, Z.; Cochran, J.R.; Cheng, Z.; Felsher, D.; Kjaer, A.; Willmann, J.K.; et al. PET Imaging of tumor neovascularization in a transgenic mouse model with a novel Cu-64-DOTA-knottin peptide. Cancer Res. 2010, 70, 9022-9030.
32. Li, W.P.; Meyer, L.A.; Capretto, D.A.; Sherman, C.D.; Anderson, C. J. Receptor-binding, biodistribution, and metabolism studies of (64)Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. Cancer Biother. Radiopharm. 2008, 23, 158-171. (Pubitemid 351630188)
33. Cai, W.B.; Wu, Y.; Chen, K.; Cao, Q.Z.; Tice, D.A.; Chen, X.Y. In vitro and in vivo characterization of Cu-64-labeled Abegrin (TM) a humanized monoclonal antibody against integrin alpha(v)beta(3). Cancer Res. 2006, 66, 9673-9681. (Pubitemid 44623667)
34. Cai, W.B.; Ebrahimnejad, A.; Chen, K.; Cao, Q.Z.; Li, Z.B.; Tice, D.A.; Chen, X.Y. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. Eur. J. Nucl. Med. Mol. Imaging 2007. 34, 2024-2036. (Pubitemid 350212123)
35. Philpott, G.W.; Schwarz, S.W.; Anderson, C.J.; Dehdashti, F.; Connett, J.M.; Zinn, K.R.; Meares, C.F.; Cutler, P.D.; Welch, M.J.; Siegel, B.A. RadioimmunoPET: Detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J. Nucl. Med. 1995, 36. 1818-1824.
36. Veleva, A.N.; Nepal, D.B.; Frederick, C.B.; Schwab, J.; Lockyer, P.; Yuan, H.; Lalush, D.S.; Patterson, C. Efficient in vivo selection of a novel tumor-associated peptide from a phage display library. Molecules 2011, 16, 900-914.
37. Deutscher, S.L. Phage display in molecular imaging and diagnosis of cancer. Chem. Rev. 2010, 110. 3196-3211.
38. Tanaka, T.; Furukawa, T.; Fujieda, S.; Kasamatsu, S.; Yonekura, Y.; Fujibayashi, Y. Doubletracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models. Nucl. Med. Biol. 2006, 33, 743-750. (Pubitemid 44247730)
39. MIRD Pamphlet No. 11. Society of Nuclear Medicine: New York, NY, USA, 1975.
40. Veleva, A.N.; Cooper, S.L.; Patterson, C. Selection and initial characterization of novel peptide ligands that bind specifically to human blood outgrowth endothelial cells. Biotechnol. Bioeng. 2007. 98, 306-312. (Pubitemid 47325848)
41. Kume, M.; Carey, P.C.; Gaehle, G.; Madrid, E.; Voller, T.; Margenau, W.; Welch, M.J.; Lapi, S.E. A semi-automated system for the routine production of copper-64. Appl. Radiat. Isot. 2012, 70, 1803-1806.
42. Yuan, H.; Schroeder, T.; Bowsher, J.E.; Hedlund, L.W.; Wong, T.; Dewhirst, M.W. Intertumoral differences in hypoxia selectivity of the PET imaging agent Cu-64(II)-diacetyl-bis(N-4-methylthiosemicarbazone). J. Nucl. Med. 2006, 47, 989-998. (Pubitemid 46939952)
43. Willis, M.S.; Dyer, L.A.; Ren, R.; Lockyer, P.; Moreno-Miralles, I.; Schisler. J.C.; Patterson, C. BMPER regulates cardiomyocyte size and vessel density in vivo. Cardiovasc. Pathol. 2012, 22, 228-240.